Company Valuation: Trinity Biotech plc

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 79.64 29.89 37.73 16.39 15.34 14.69
Change - -62.47% 26.22% -56.55% -6.42% -4.25%
Enterprise Value (EV) 1 156.6 103.2 103.3 80.13 110.9 147.5
Change - -34.14% 0.18% -22.47% 38.45% 32.99%
P/E -12.5x 38.2x -0.81x -0.68x -0.48x -0.39x
PBR -35.9x -93.7x -17.3x -0.69x -0.45x -0.21x
PEG - -0x 0x 0x 0x -0.04x
Capitalization / Revenue 0.78x 0.32x 0.5x 0.29x 0.25x 0.34x
EV / Revenue 1.54x 1.11x 1.38x 1.41x 1.8x 3.37x
EV / EBITDA 7.62x 9.78x -10.9x -5.6x -8.51x -17.9x
EV / EBIT 8.49x 11.6x -9.46x -4.98x -8.1x -15.5x
EV / FCF 25x -133x -12.2x -6.24x -15.8x -13.2x
FCF Yield 4.01% -0.75% -8.2% -16% -6.34% -7.59%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -1.528 0.1871 -6.078 -3.138 -1.832 -2.012
Distribution rate - - - - - -
Net sales 1 102 92.96 74.78 56.83 61.56 43.78
EBITDA 1 20.56 10.55 -9.521 -14.3 -13.03 -8.243
EBIT 1 18.45 8.901 -10.92 -16.08 -13.7 -9.546
Net income 1 -6.388 0.875 -41.01 -24.02 -31.79 -37.38
Net Debt 1 77.01 73.28 65.62 63.74 95.6 132.8
Reference price 2 19.0500 7.1500 4.9500 2.1450 0.8802 0.7910
Nbr of stocks (in thousands) 4,180 4,180 7,622 7,642 17,426 18,566
Announcement Date 30/04/21 02/05/22 16/05/23 30/04/24 16/05/25 30/04/26
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 7.51M
-53.48x16.1x-117.84x-.--% 20.55B
17.47x1.98x8.26x1.48% 9.81B
23.75x4.49x12.65x - 6.84B
-54.83x8.42x-71.65x-.--% 5.65B
19.33x6.63x14.99x2.98% 5.22B
167.7x4.2x27.48x-.--% 4.66B
20.33x3.57x11.09x1.87% 4.23B
16.62x - - 3.86% 2.79B
Average 19.61x 6.48x -16.43x 1.45% 6.64B
Weighted average by Cap. -1.01x 8.74x -42.23x 0.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. TRIB Stock
  4. Valuation Trinity Biotech plc